Why CTI BioPharma Stock Crushed the Market Today
Copyright 1995-2022 The Motley Fool. All rights reserved.
finance
2022-10-17 22:55:12

The stock market as a whole had a fine Monday, but CTI BioPharma (CTIC 4.49%) had a particularly good time of it. The China-based biotech's shares leaped nearly 5% on the back of not one but two positive analyst initiations. 
So what
The two institutions launching their coverage of CTI BioPharma stock were Taiwan-headquartered SinoPac Financial Holdings and U.S. investment bank SVB Leerink. Both the former's Kenneth Shields and the latter's Andrew Berens were bullish on the stock, tagging it with the equivalent of buy recommendations.
